Edgewise Therapeutics, Inc. (EWTX)

NASDAQ: EWTX · Real-Time Price · USD

43.18

-0.38 (-0.87%)

At close: Aug 13, 2026, 4:00 PM EDT

42.70

-0.48 (-1.11%)

Pre-market: Aug 14, 2026, 7:50 AM EDT

Edgewise Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,690	2,637	2,532	771	566	756
Market Cap Growth	232.45%	4.12%	228.53%	36.29%	-25.23%	-
Enterprise Value	4,232	2,110	2,067	457.78	217.98	475.58
Last Close Price	43.18	24.82	26.70	10.94	8.94	15.28
PB Ratio	10.39	5.05	5.51	2.42	1.63	2.76
P/TBV Ratio	10.27	4.89	5.37	2.19	1.38	2.09
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0
Net Debt / Equity Ratio	-1.02	-1.01	-1.01	-0.98	-1.00	-1.02
Net Debt / EBITDA Ratio	2.11	2.78	2.97	2.78	4.89	6.54
Net Debt / FCF Ratio	2.88	3.65	4.22	3.20	5.97	8.22
Quick Ratio	15.86	19.37	19.71	18.98	21.22	26.69
Current Ratio	16.24	19.85	19.93	19.50	21.53	26.97
Return on Equity (ROE)	-40.65%	-34.19%	-34.40%	-30.10%	-21.78%	-21.34%
Return on Assets (ROA)	-42.41%	-36.83%	-38.42%	-32.34%	-21.97%	-20.76%
Return on Invested Capital (ROIC)	-1508.94%	-1696.71%	-1205.65%	-924.92%	-1177.62%	-2928.84%
Return on Capital Employed (ROCE)	-44.86%	-38.74%	-40.40%	-33.94%	-22.92%	-21.53%
Buyback Yield / Dilution	-9.70%	-11.38%	-45.02%	-18.90%	-42.82%	-4977.96%
Total Shareholder Return	-9.70%	-11.38%	-45.02%	-18.90%	-42.82%	-4977.96%

SEC Filings: 10-K · 10-Q